Abstract:Background MicroRNAs (miRNAs) are short, non-coding RNAs (~22 nt) that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. Although miR-196a has been implicated in several other cancers, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present study was to examine the expression pattern of miR-196a in NSCLC and its clinical significance, as well as its biological role in tumor progression. Methods Expression of miR-196a was analyzed in 34 NSCLC tissues and five NSCLC cell lines by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The effect of DNA methylation on miR-196a expression was investigated by 5-aza-2-deoxy-cytidine treatment and bisulfite sequencing. The effect of miR-196a on proliferation was evaluated by MTT and colony formation assays, and cell migration and invasion were evaluated by transwell assays. Analysis of target protein expression was determined by western blotting. Luciferase reporter plasmids were constructed to confirm the action of miR-196a on downstream target genes, including HOXA5 . Differences between the results were tested for significance using Student’s t-test (two-tailed). Results miR-196a was highly expressed both in NSCLC samples and cell lines compared with their corresponding normal counterparts, and the expression of miR-196a may be affected by DNA demethylation. Higher expression of miR-196a in NSCLC tissues was associated with a higher clinical stage, and also correlated with NSCLC lymph-node metastasis. In vitro functional assays demonstrated that modulation of miR-196a expression affected NSCLC cell proliferation, migration and invasion. Our analysis showed that miR-196a suppressed the expression of HOXA5 both at the mRNA and protein levels, and luciferase assays confirmed that miR-196a directly bound to the 3’untranslated region of HOXA5. Knockdown of HOXA5 expression in A549 cells using RNAi was shown to promote NSCLC cell proliferation, migration and invasion. Finally, we observed an inverse correlation between HOXA5 and miR-196a expression in NSCLC tissues. Conclusions Our findings indicate that miR-196a is significantly up-regulated in NSCLC tissues, and regulates NSCLC cell proliferation, migration and invasion, partially via the down-regulation of HOXA5. Thus, miR-196a may represent a potential therapeutic target for NSCLC intervention.

microRNA-510-5p promotes thyroid cancer cell proliferation, migration, and invasion through suppressing SNHG15.

SNHG15 functions as a tumor suppressor in thyroid cancer.

Long Noncoding RNA Small Nucleolar RNA Host Gene 12 Promotes Papillary Thyroid Carcinoma Cell Growth and Invasion by Targeting Mir-16-5p.

Biological functions of LncRNA SNHG14 in the development of thyroid cancer cells via targeting miR-206

Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p

Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3β signal pathway

LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma

Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p

Long noncoding RNA small nucleolar RNA host gene 15 deteriorates liver cancer via microRNA ‐18b‐5p/ LIM‐only 4 axis

LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma

LncRNA SNHG16 Promotes Hepatocellular Carcinoma Proliferation, Migration and Invasion by Regulating miR-186 Expression.

Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer.

SNHG20 promotes the development of laryngeal squamous cell carcinoma via miR-342-3p/MTDH axis

LncRNA SNHG15 modulates gastric cancer tumorigenesis by impairing miR-506-5p expression

Increased Expression of Long Non-Coding RNA SNHG16 Correlates with Tumor Progression and Poor Prognosis in Non-Small Cell Lung Cancer

LncRNA SNHG14 Potentiates Pancreatic Cancer Progression Via Modulation of Annexin A2 Expression by Acting As a Competing Endogenous RNA for Mir‐613

SNHG5 Functions As Competitive RNA with Mir-23C to Regulate HMGB2 Expression in Hepatocellular Carcinoma.

Statistical Analysis of Long-Chain Non-Coding RNA SNHG1 Influencing the Proliferation of Non-Small Cell Lung Cancer A549 Cells by Competitive Binding to Microrna-101.

Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR‐495

MicroRNA-196a Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Targeting HOXA5

Expression and change of miR-199b-5p, s HLA-G in thyroid carcinoma